Other Species / Isoforms
  CRIP2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K10
SKCPKCDKtVyFAEK
0 1
CRIP2 (human) SKCPKCDKtVyFAEK K10
CRIP2 (mouse) SKCPKCDKtVyFAEk K10
CRIP2 (rat) SKCPKCDkTVyFAEk K10-ac
T11-p
KCPKCDKtVyFAEKV
Upstream
0 3
Treatment
  • ischemia
CRIP2 (human) KCPKCDKtVyFAEKV T11-p
CRIP2 (mouse) KCPKCDKtVyFAEkV T11-p
CRIP2 (rat) KCPKCDkTVyFAEkV T11
Y13-p
PKCDKtVyFAEKVSS
Upstream
0 43
Treatment
  • gefitinib
CRIP2 (human) PKCDKtVyFAEKVSS Y13-p
CRIP2 (mouse) PKCDKtVyFAEkVSS Y13-p
CRIP2 (rat) PKCDkTVyFAEkVSS Y13-p
K17
KtVyFAEKVSSLGkD
0 1
CRIP2 (human) KtVyFAEKVSSLGkD K17
CRIP2 (mouse) KtVyFAEKVSSLGKD K17
CRIP2 (rat) kTVyFAEkVSSLGkD K17-ac
K17
KtVyFAEKVSSLGkD
0 1
CRIP2 (human) KtVyFAEKVSSLGkD K17
CRIP2 (mouse) KtVyFAEkVSSLGKD K17-ub
CRIP2 (rat) kTVyFAEKVSSLGkD K17
K23-ac
EKVSSLGkDWHKFCL
0 4
CRIP2 (human) EKVSSLGkDWHKFCL K23-ac
CRIP2 (mouse) EkVSSLGKDWHKFCL K23
CRIP2 (rat) EkVSSLGkDWHkFCL K23-ac
K27
SLGkDWHKFCLKCER
0 1
CRIP2 (human) SLGkDWHKFCLKCER K27
CRIP2 (mouse) SLGKDWHKFCLKCER K27
CRIP2 (rat) SLGkDWHkFCLkCER K27-ac
K31
DWHKFCLKCERCSKt
0 1
CRIP2 (human) DWHKFCLKCERCSKt K31
CRIP2 (mouse) DWHKFCLKCERCNKt K31
CRIP2 (rat) DWHkFCLkCERCNKT K31-ac
T38-p
KCERCSKtLtPGGHA
0 4
CRIP2 (human) KCERCSKtLtPGGHA T38-p
CRIP2 (mouse) KCERCNKtLTPGGHA T38-p
CRIP2 (rat) kCERCNKTLTPGGHA T38
T40-p
ERCSKtLtPGGHAEH
0 2
CRIP2 (human) ERCSKtLtPGGHAEH T40-p
CRIP2 (mouse) ERCNKtLTPGGHAEH T40
CRIP2 (rat) ERCNKTLTPGGHAEH T40
Y58-p
PFCHKPCyATLFGPK
0 1
CRIP2 (human) PFCHKPCyATLFGPK Y58-p
CRIP2 (mouse) PFCHKPCYATLFGPK Y58
CRIP2 (rat) PFCHKPCYATLFGPK Y58
S74-p
VNIGGAGsyIyEKPL
Upstream
0 7
Treatment
  • ischemia
CRIP2 (human) VNIGGAGsyIyEKPL S74-p
CRIP2 (mouse) VNIGGAGsyIyEKPQ S74-p
CRIP2 (rat) VNIGGAGSYIYEkPP S74
Y75-p
NIGGAGsyIyEKPLA
Upstream
0 21
Treatment
  • gefitinib
CRIP2 (human) NIGGAGsyIyEKPLA Y75-p
CRIP2 (mouse) NIGGAGsyIyEKPQT Y75-p
CRIP2 (rat) NIGGAGSYIYEkPPT Y75
Y77-p
GGAGsyIyEKPLAEG
Upstream
0 323
Treatment
  • ephrin_B1
  • erlotinib
CRIP2 (human) GGAGsyIyEKPLAEG Y77-p
CRIP2 (mouse) GGAGsyIyEKPQTEA Y77-p
CRIP2 (rat) GGAGSYIYEkPPTEA Y77
K79
AGsyIyEKPLAEGPQ
0 1
CRIP2 (human) AGsyIyEKPLAEGPQ K79
CRIP2 (mouse) AGsyIyEKPQTEAPQ K79
CRIP2 (rat) AGSYIYEkPPTEAPQ K79-ac
T88-p
LAEGPQVtGPIEVPA
0 3
CRIP2 (human) LAEGPQVtGPIEVPA T88-p
CRIP2 (mouse) QTEAPQVTGPIEVPV T88
CRIP2 (rat) PTEAPQVTGPIEVPV T88
T88
LAEGPQVTGPIEVPA
0 2
CRIP2 (human) LAEGPQVTGPIEVPA T88
CRIP2 (mouse) QTEAPQVtGPIEVPV T88-gl
CRIP2 (rat) PTEAPQVTGPIEVPV T88
S104-p
RAEERKAsGPPKGPs
Upstream
1 5
Treatment
  • ischemia
CRIP2 (human) RAEERKAsGPPKGPs S104-p
CRIP2 (mouse) RTEERKTsGPPKGPS S104-p
CRIP2 (rat) RTEERKTsGPPKGPS S104-p
S111-p
sGPPKGPsRAssVtT
0 4
CRIP2 (human) sGPPKGPsRAssVtT S111-p
CRIP2 (mouse) sGPPKGPSkASsVTT S111
CRIP2 (rat) sGPPKGPSKASsVTt S111
R112
GPPKGPsRAssVtTF
0 1
CRIP2 (human) GPPKGPsRAssVtTF R112
CRIP2 (mouse) GPPKGPSkASsVTTF K112-ub
CRIP2 (rat) GPPKGPSKASsVTtF K112
S114-p
PKGPsRAssVtTFtG
0 6
CRIP2 (human) PKGPsRAssVtTFtG S114-p
CRIP2 (mouse) PKGPSkASsVTTFTG S114
CRIP2 (rat) PKGPSKASsVTtFTG S114
S115-p
KGPsRAssVtTFtGE
Upstream
0 17
Treatment
  • ischemia
CRIP2 (human) KGPsRAssVtTFtGE S115-p
CRIP2 (mouse) KGPSkASsVTTFTGE S115-p
CRIP2 (rat) KGPSKASsVTtFTGE S115-p
T117-p
PsRAssVtTFtGEPN
0 1
CRIP2 (human) PsRAssVtTFtGEPN T117-p
CRIP2 (mouse) PSkASsVTTFTGEPN T117
CRIP2 (rat) PSKASsVTtFTGEPN T117
T118
sRAssVtTFtGEPNt
0 1
CRIP2 (human) sRAssVtTFtGEPNt T118
CRIP2 (mouse) SkASsVTTFTGEPNM T118
CRIP2 (rat) SKASsVTtFTGEPNM T118-p
T120-p
AssVtTFtGEPNtCP
0 1
CRIP2 (human) AssVtTFtGEPNtCP T120-p
CRIP2 (mouse) ASsVTTFTGEPNMCP T120
CRIP2 (rat) ASsVTtFTGEPNMCP T120
T125-p
TFtGEPNtCPRCSKk
0 4
CRIP2 (human) TFtGEPNtCPRCSKk T125-p
CRIP2 (mouse) TFTGEPNMCPRCNKR M125
CRIP2 (rat) tFTGEPNMCPRCNKR M125
K132-ac
tCPRCSKkVyFAEkV
0 1
CRIP2 (human) tCPRCSKkVyFAEkV K132-ac
CRIP2 (mouse) MCPRCNKRVYFAEkV R132
CRIP2 (rat) MCPRCNKRVYFAEkV R132
Y134-p
PRCSKkVyFAEkVTS
0 24
CRIP2 (human) PRCSKkVyFAEkVTS Y134-p
CRIP2 (mouse) PRCNKRVYFAEkVTS Y134
CRIP2 (rat) PRCNKRVYFAEkVTS Y134
K138-ac
KkVyFAEkVTSLGkD
0 4
CRIP2 (human) KkVyFAEkVTSLGkD K138-ac
CRIP2 (mouse) KRVYFAEKVTSLGKD K138
CRIP2 (rat) KRVYFAEkVTSLGkD K138-ac
K138
KkVyFAEKVTSLGkD
0 1
CRIP2 (human) KkVyFAEKVTSLGkD K138
CRIP2 (mouse) KRVYFAEkVTSLGKD K138-ub
CRIP2 (rat) KRVYFAEKVTSLGkD K138
K144-ac
EkVTSLGkDWHRPCL
0 2
CRIP2 (human) EkVTSLGkDWHRPCL K144-ac
CRIP2 (mouse) EkVTSLGKDWHRPCL K144
CRIP2 (rat) EkVTSLGkDWHRPCL K144-ac
T159-p
RCERCGKtLtPGGHA
0 1
CRIP2 (human) RCERCGKtLtPGGHA T159-p
CRIP2 (mouse) RCERCSKTLTPGGHA T159
CRIP2 (rat) RCERCSKTLTPGGHA T159
T161-p
ERCGKtLtPGGHAEH
0 2
CRIP2 (human) ERCGKtLtPGGHAEH T161-p
CRIP2 (mouse) ERCSKTLTPGGHAEH T161
CRIP2 (rat) ERCSKTLTPGGHAEH T161
K176
DGQPYCHKPCYGILF
0 2
CRIP2 (human) DGQPYCHKPCYGILF K176
CRIP2 (mouse) DGQPYCHkPCYGILF K176-ac
CRIP2 (rat) DGQPYCHKPCYGILF K176
S195-p
VNTGAVGsyIyDRDP
Upstream
0 10
Treatment
  • ischemia
CRIP2 (human) VNTGAVGsyIyDRDP S195-p
CRIP2 (mouse) VNTGAVGsYIyDkDP S195-p
CRIP2 (rat) VNTGAVGSYIYDkDP S195
Y196-p
NTGAVGsyIyDRDPE
Upstream
0 23
Treatment
  • gefitinib
CRIP2 (human) NTGAVGsyIyDRDPE Y196-p
CRIP2 (mouse) NTGAVGsYIyDkDPE Y196
CRIP2 (rat) NTGAVGSYIYDkDPE Y196
Y198-p
GAVGsyIyDRDPEGk
Upstream
0 49
Treatment
  • erlotinib
  • gefitinib
CRIP2 (human) GAVGsyIyDRDPEGk Y198-p
CRIP2 (mouse) GAVGsYIyDkDPEGT Y198-p
CRIP2 (rat) GAVGSYIYDkDPEGT Y198
R200
VGsyIyDRDPEGkVQ
0 3
CRIP2 (human) VGsyIyDRDPEGkVQ R200
CRIP2 (mouse) VGsYIyDkDPEGTVQ K200-ac
CRIP2 (rat) VGSYIYDkDPEGTVQ K200-ac
K205-ac
yDRDPEGkVQP____
0 1
CRIP2 (human) yDRDPEGkVQP____ K205-ac
CRIP2 (mouse) yDkDPEGTVQP____ T205
CRIP2 (rat) YDkDPEGTVQP____ T205